fda statement bpc-157 not approved for human use compounding Just Cleared a Major Regulatory Hurdle F.D.A. Panel's Vote on Peptides

BPC-157 and TB-500: The Wolverine Blend for Tissue and Injury Recovery When people picture peptides for athletes and recovery, they are usually picturing BPC-157 and TB-500, often combined in what clinics call a Wolverine blend

The 1 mg dose is primarily about establishing tolerance, not producing dramatic results

As of 2026, cagrilintide is not FDA approved for any indication

Not for use in therapeutic or diagnostic procedures

Patients may ask about DSIP if they are dealing with: Trouble falling asleep Trouble staying asleep Light or non-restorative sleep Stress-related sleep disruption Burnout and fatigue Recovery concerns Shift-work or circadian rhythm issues Mood-related sleep problems Anxiety-related nighttime wakefulness These concerns deserve real care